Improving adherence with medication;Verbesserung und auswirkungen medikamentöser therapietreue

Deutsches Arzteblatt International

Volumn 111, Issue 4, 2014, Pages 41-47

  Matthes, Jan ^a   Albus, Christian ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOCTOR PATIENT RELATION; DRUG SELF ADMINISTRATION; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; HYPERTENSION; MALE; MEDICATION COMPLIANCE; META ANALYSIS; PATIENT EDUCATION; PATIENT PARTICIPATION; PREVALENCE; REMINDER SYSTEM; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; HYPERTENSION; MALE; MEDICATION ADHERENCE; PATIENT EDUCATION AS TOPIC; PATIENT PARTICIPATION; PHYSICIAN-PATIENT RELATIONS; PREVALENCE; REMINDER SYSTEMS; SELF ADMINISTRATION; TREATMENT OUTCOME;

EID: 84894505474     PISSN: 18660452     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2014.0041     Document Type: Review

References (40)

1. General Medical Council. Consent: patients and doctors making decisions together 2008.
2. Sabaté E: Adherence to long-term therapies: evidence for action. Geneva, Switzerland: World Health Organization 2003.
3. Dunbar J: Adherence measures and their utility. Control Clin Trials 1984; 5: 515-21.
4. Blaschke TF, Osterberg L, Vrijens B, Urquhart J: Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories. Annu Rev Pharmacol Toxicol 2012; 52: 275-301.
5. Cramer JA, Roy A, Burrell A, et al.: Medication compliance and persistence: terminology and definitions. Value Health 2008; 11: 44-7.
6. Osterberg L, Blaschke T: Adherence to medication. N Engl J Med 2005; 353: 487-97.
7. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS: Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005; 43: 521-30.
8. Simpson SH, Eurich DT, Majumdar SR, et al.: A meta-analysis of the association between adherence to drug therapy and mortality. BMJ 2006; 333: 15.
9. Möbes J: Compliance: Neue Positionen am Beispiel des Diabetes mellitus. Z Allg Med 2003; 79: 238-43.
10. Ho PM, Bryson CL, Rumsfeld JS: Medication adherence: its importance in cardiovascular outcomes. Circulation 2009; 119: 3028-35.
11. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X: Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008: CD000011.
12. Kripalani S, Yao X, Haynes RB: Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med 2007; 167: 540-50.
13. Friedman RH, Kazis LE, Jette A, et al.: A telecommunications system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control. Am J Hypertens 1996; 9: 285-92.
14. Haynes RB, Sackett DL, Gibson ES, et al.: Improvement of medication compliance in uncontrolled hypertension. Lancet 1976; 1: 1265-8.
15. Jarab AS, Alqudah SG, Mukattash TL, Shattat G, Al-Qirim T: Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan. J Manag Care Pharm 2012; 18: 516-26.
16. Lee JK, Grace KA, Taylor AJ: Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and lowdensity lipoprotein cholesterol: a randomized controlled trial. JAMA 2006; 296: 2563-71.
17. Marquez Contreras E, Vegazo Garcia O, Claros NM, et al.: Efficacy of telephone and mail intervention in patient compliance with antihypertensive drugs in hypertension. ETECUM-HTA study. Blood Press 2005; 14: 151-8.
18. Marquez-Contreras E, Martell-Claros N, Gil-Guillen V, et al.: Efficacy of a home blood pressure monitoring programme on therapeutic compliance in hypertension: the EAPACUM-HTA study. J Hypertens 2006; 24: 169-75.
19. Morgado M, Rolo S, Castelo-Branco M: Pharmacist intervention program to enhance hypertension control: a randomised controlled trial. Int J Clin Pharm 2011; 33: 132-40.
20. Obreli-Neto PR, Guidoni CM, de Oliveira Baldoni A, et al.: Effect of a 36-month pharmaceutical care program on pharmacotherapy adherence in elderly diabetic and hypertensive patients. Int J Clin Pharm 2011; 33: 642-9.
21. Ogedegbe GO, Boutin-Foster C, Wells MT, et al.: A randomized controlled trial of positive-affect intervention and medication adherence in hypertensive African Americans. Arch Intern Med 2012; 172: 322-6.
22. Pladevall M, Brotons C, Gabriel R, et al.: Multicenter cluster-randomized trial of a multifactorial intervention to improve antihypertensive medication adherence and blood pressure control among patients at high cardiovascular risk (the COM99 study). Circulation 2010; 122: 1183-91.
23. Rudd P, Miller NH, Kaufman J, et al.: Nurse management for hypertension. A systems approach. Am J Hypertens 2004; 17: 921-7.
24. Schneider PJ, Murphy JE, Pedersen CA: Impact of medication packaging on adherence and treatment outcomes in older ambulatory patients. J Am Pharm Assoc (2003). 2008; 48: 58-63.
25. Sookaneknun P, Richards RM, Sanguansermsri J, Teerasut C: Pharmacist involvement in primary care improves hypertensive patient clinical outcomes. Ann Pharmacother 2004; 38: 2023-8.
26. Becker LA, Glanz K, Sobel E, Mossey J, Zinn SL, Knott KA: A randomized trial of special packaging of antihypertensive medications. J Fam Pract 1986; 22: 357-61.
27. de Castro MS, Fuchs FD, Santos MC, et al.: Pharmaceutical care program for patients with uncontrolled hypertension. Report of a double-blind clinical trial with ambulatory blood pressure monitoring. Am J Hypertens 2006; 19: 528-33.
28. Johnson AL, Taylor DW, Sackett DL, Dunnett CW, Shimizu AG: Selfrecording of blood pressure in the management of hypertension. Can Med Assoc J 1978; 119: 1034-9.
29. Matsumura K, Arima H, Tominaga M, et al.: Does a combination pill of antihypertensive drugs improve medication adherence in Japanese? A randomized controlled trial. Circ J 2012; 76: 1415-22.
30. Ogedegbe G, Chaplin W, Schoenthaler A, et al.: A practice-based trial of motivational interviewing and adherence in hypertensive African Americans. Am J Hypertens 2008; 21: 1137-43.
31. Rinfret S, Lussier MT, Peirce A, et al.: The impact of a multidisciplinary information technology-supported program on blood pressure control in primary care. Circ Cardiovasc Qual Outcomes 2009; 2: 170-7.
32. Sackett DL, Haynes RB, Gibson ES, et al.: Randomised clinical trial of strategies for improving medication compliance in primary hypertension. Lancet 1975; 1: 1205-7.
33. Schroeder K, Fahey T, Hollinghurst S, Peters TJ: Nurse-led adherence support in hypertension: a randomized controlled trial. Fam Pract 2005; 22: 144-51.
34. McDonald HP, Garg AX, Haynes RB: Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA 2002; 288: 2868-79.
35. Kjellgren KI, Ahlner J, Saljo R: Taking antihypertensive medication-controlling or co-operating with patients? Int J Cardiol 1995; 47: 257-68.
36. Melnikow J, Kiefe C: Patient compliance and medical research: issues in methodology. J Gen Intern Med 1994; 9: 96-105.
37. Deinzer A, Babel H, Veelken R, Kohnen R, Schmieder RE: [Shared decision-making with hypertensive patients. Results of an implementation in Germany]. Dtsch Med Wochenschr 2006; 131: 2592-6.
38. Kronish IM, Woodward M, Sergie Z, Ogedegbe G, Falzon L, Mann DM: Meta-analysis: impact of drug class on adherence to antihypertensives. Circulation 2011; 123: 1611-21.
39. Lowy A, Munk VC, Ong SH, et al.: Effects on blood pressure and cardiovascular risk of variations in patients' adherence to prescribed antihypertensive drugs: role of duration of drug action. Int J Clin Pract 2011; 65: 41-53.
40. Perk J, De Backer G, Gohlke H, et al.: European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012; 33: 1635-701.